[
  {
    "ts": null,
    "headline": "Iftekhar Ahmed: The Global Strategist Quietly Transforming Healthcare Leadership",
    "summary": "With a legacy of global impact, Iftekhar Ahmed brings strategic clarity, cultural fluency, and people-centered leadership to the forefront of healthcare innovation at Danaher. WASHINGTON, DC / ACCESS Newswire / August 12, 2025 / In a rapidly evolving ...",
    "url": "https://finnhub.io/api/news?id=62e33dd51d1e8a565c182e6b32f891ee04539bada5fd39fd94618109e4c9018f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755027900,
      "headline": "Iftekhar Ahmed: The Global Strategist Quietly Transforming Healthcare Leadership",
      "id": 136323083,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "With a legacy of global impact, Iftekhar Ahmed brings strategic clarity, cultural fluency, and people-centered leadership to the forefront of healthcare innovation at Danaher. WASHINGTON, DC / ACCESS Newswire / August 12, 2025 / In a rapidly evolving ...",
      "url": "https://finnhub.io/api/news?id=62e33dd51d1e8a565c182e6b32f891ee04539bada5fd39fd94618109e4c9018f"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=ae39f63478d4a5092642d02b131a29e309fe8f2bfc66c7a640114e749799de18",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755016560,
      "headline": "Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 136333551,
      "image": "",
      "related": "DHR",
      "source": "MarketWatch",
      "summary": "Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=ae39f63478d4a5092642d02b131a29e309fe8f2bfc66c7a640114e749799de18"
    }
  },
  {
    "ts": null,
    "headline": "Genedata Next-Gen Software to Power GMP-Compliant NGS in Biopharma Manufacturing",
    "summary": "Genedata, a Danaher company, and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new release of Genedata Selector®. This end-to-end solution automates next-generation sequencing (NGS) data processing and analysis, accelerating decision-making for more efficient quality control of advanced therapies. The new version of Genedata Selector further enhances data integrity by seamlessly connecting systems, facilitating efficient transfer of data, proj",
    "url": "https://finnhub.io/api/news?id=ce113e7af8fa5d242d6f20c9a12809ceb863efdfa055f62c75187b1fceae10ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755001800,
      "headline": "Genedata Next-Gen Software to Power GMP-Compliant NGS in Biopharma Manufacturing",
      "id": 136316196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Genedata, a Danaher company, and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new release of Genedata Selector®. This end-to-end solution automates next-generation sequencing (NGS) data processing and analysis, accelerating decision-making for more efficient quality control of advanced therapies. The new version of Genedata Selector further enhances data integrity by seamlessly connecting systems, facilitating efficient transfer of data, proj",
      "url": "https://finnhub.io/api/news?id=ce113e7af8fa5d242d6f20c9a12809ceb863efdfa055f62c75187b1fceae10ca"
    }
  },
  {
    "ts": null,
    "headline": "STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories",
    "summary": "The STD Diagnostic Market is projected to reach $17.93 billion by 2033, growing from $9.82 billion in 2024 at a CAGR of 6.92% during 2025-2033. Key growth drivers include increased STD prevalence, technological advancements in diagnostics, and enhanced accessibility to healthcare. Government initiatives and improved public awareness also bolster the market. Segments analyzed include products, testing types, and global regions, emphasizing the demand for point-of-care testing and at-home kits. Si",
    "url": "https://finnhub.io/api/news?id=bd7e53898c1d713d814e527a001f099b8f104ddb804fb0a2fd5341ab3ffb73cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754988540,
      "headline": "STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories",
      "id": 136316074,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "The STD Diagnostic Market is projected to reach $17.93 billion by 2033, growing from $9.82 billion in 2024 at a CAGR of 6.92% during 2025-2033. Key growth drivers include increased STD prevalence, technological advancements in diagnostics, and enhanced accessibility to healthcare. Government initiatives and improved public awareness also bolster the market. Segments analyzed include products, testing types, and global regions, emphasizing the demand for point-of-care testing and at-home kits. Si",
      "url": "https://finnhub.io/api/news?id=bd7e53898c1d713d814e527a001f099b8f104ddb804fb0a2fd5341ab3ffb73cb"
    }
  }
]